AAAAAA

   
Results: 1-9 |
Results: 9
A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors
Authors: Walker, MC Kurumbail, RG Kiefer, JR Moreland, KT Koboldt, CM Isakson, PC Seibert, K Gierse, JK
Citation: Mc. Walker et al., A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors, BIOCHEM J, 357, 2001, pp. 709-718
N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl] sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration
Authors: Talley, JJ Bertenshaw, SR Brown, DL Carter, JS Graneto, MJ Kellogg, MS Koboldt, CM Yuan, JH Zhang, YY Seibert, K
Citation: Jj. Talley et al., N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl] sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration, J MED CHEM, 43(9), 2000, pp. 1661-1663
4-[5-methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2
Authors: Talley, JJ Brown, DL Carter, JS Graneto, MJ Koboldt, CM Masferrer, JL Perkins, WE Rogers, RS Shaffer, AF Zhang, YY Zweifel, BS Seibert, K
Citation: Jj. Talley et al., 4-[5-methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: A potent and selective inhibitor of COX-2, J MED CHEM, 43(5), 2000, pp. 775-777
Selective cyclooxygenase-2 inhibitors: Heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents
Authors: Khanna, IK Yu, Y Huff, RM Weier, RM Xu, XD Koszyk, FJ Collins, PW Cogburn, JN Isakson, PC Koboldt, CM Masferrer, JL Perkins, WE Seibert, K Veenhuizen, AW Yuan, JH Yang, DC Zhang, YY
Citation: Ik. Khanna et al., Selective cyclooxygenase-2 inhibitors: Heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents, J MED CHEM, 43(16), 2000, pp. 3168-3185
Characterization of the recombinant IKK1/IKK2 heterodimer - Mechanisms regulating kinase activity
Authors: Huynh, QK Boddupalli, H Rouw, SA Koboldt, CM Hall, T Sommers, C Hauser, SD Pierce, JL Combs, RG Reitz, BA Diaz-Collier, JA Weinberg, RA Hood, BL Kilpatrick, BF Tripp, CS
Citation: Qk. Huynh et al., Characterization of the recombinant IKK1/IKK2 heterodimer - Mechanisms regulating kinase activity, J BIOL CHEM, 275(34), 2000, pp. 25883-25891
Design and synthesis of sulfonyl-substituted 4,5-diarylthiazoles as selective cyclooxygenase-2 inhibitors
Authors: Carter, JS Rogier, DJ Graneto, MJ Seibert, K Koboldt, CM Zhang, Y Talley, JJ
Citation: Js. Carter et al., Design and synthesis of sulfonyl-substituted 4,5-diarylthiazoles as selective cyclooxygenase-2 inhibitors, BIOORG MED, 9(8), 1999, pp. 1167-1170
Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors
Authors: Carter, JS Kramer, S Talley, JJ Penning, T Collins, P Graneto, MJ Seibert, K Koboldt, CM Masferrer, J Zweifel, B
Citation: Js. Carter et al., Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors, BIOORG MED, 9(8), 1999, pp. 1171-1174
Kinetic basis for selective inhibition of cyclo-oxygenases
Authors: Gierse, JK Koboldt, CM Walker, MC Seibert, K Isakson, PC
Citation: Jk. Gierse et al., Kinetic basis for selective inhibition of cyclo-oxygenases, BIOCHEM J, 339, 1999, pp. 607-614
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)
Authors: Talley, JJ Bertenshaw, SR Brown, DL Carter, JS Graneto, MJ Koboldt, CM Masferrer, JL Norman, BH Rogier, DJ Zweifel, BS Seibert, K
Citation: Jj. Talley et al., 4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2), MED RES REV, 19(3), 1999, pp. 199-208
Risultati: 1-9 |